Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_092023_Phramalogistica_114_EN_espi_170.pdf A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the LPOS requiring prior approval by the public company

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 170 / 2023
Date of issue: 2023-09-29
Short name of the issuer
SOPHARMA AD
Subject
A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the LPOS requiring prior approval by the public company
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) informs that, after a request made to the parent company, public company "Sopharma" AD by the subsidiary "Pharmalogistika" AD and consent given by the Board of Directors from 12.09.2023, today the subsidiary concluded the following transaction falling within the scope of Art. 114, para. 3 of the LPOS:

1. "Pharmalogistika" AD, UIC 130959211, as the lessor, concluded a contract with "Sopharma Trading ” AD, UIC 103267194 for the lease of a separate part with an area of 3,451.30 sq.m. from a plot of land with address Sofia, Rozhen Blvd No. 16, for a monthly rental price of BGN 3,800 (three thousand eight hundred) excluding VAT for a period of 3 /three/ years, starting from 01.10.2023 and functionally connected premises, for production, storage, office and service purposes with a total rental area of 80.80 sq.m. located in the city of Sofia, Rozhen Blvd No. 16 for a monthly rental price of BGN 347.00 (three hundred and forty-seven) excluding VAT for a period of 3 /three/ years, which will be paid monthly by bank transfer .

A) Stakeholder participation:
- Boris Anchev Borisov, who is a member of the Board of Directors of "Pharmalogistika" AD, and at the same time is a Procurator of "Sopharma Trading" AD - grounds for interest under Art. 114, para. 7, item 3 of the LPOS.

B) Value of the transaction:
The market price of the leased property is determined according to a market valuation prepared by an independent appraiser under Art. 5 of The Law of Independents Appraisers.

C) Assessment of the applicability of the conditions under Art. 114, para. 3, item 1 of the LPOS: The value of the described transaction exceeds the threshold under Art. 114, para. 3, item 1 b. b) of LPOS, which is why prior approval by the parent company, a public company, is required.
D) Assessment of the applicability of Art. 114 para. 6 of the LPOS:

Value of the assets provided for use, under the considered transaction with „Sopharma Trading“ AD under the current request in BGN BGN 88,801
Value of the assets provided for use, according to a previously concluded transaction with the same legal person under, subject to cumulation under Art. 114, para. 6 of the LPOS BGN 88,137
Total value with cumulation under Art. 114, para. 6 of the LPOS of the assets provided for use BGN 176,938
Threshold under Art. 114, para. 3, item 1, b. "b" BGN 107,950
Annexes
File Description
SFA_092023_Phramalogistica_114_EN_espi_170.pdf
SFA_092023_Phramalogistica_114_EN_espi_170.pdf
A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the LPOS requiring prior approval by the public company

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-09-29 Ognian Donev Executive Director
20230929_135734_0474741217_SFA_092023_Phramalogistica_114_EN_espi_170.pdf